Rillet's 48-Hour Unicorn Raise Rewrites ERP Playbook
Rillet hit unicorn status in 48 hours after new ARR doubled and customers crossed 600, prompting ICONIQ to lead a $100M Series C at $1B...

Created by stuart peskoe
Investor updates on US AI, biotech, climate, and foodtech startup funding, valuations, and exits
Explore the latest content tracked by Boston Tech Funding Radar
Rillet hit unicorn status in 48 hours after new ARR doubled and customers crossed 600, prompting ICONIQ to lead a $100M Series C at $1B...
As plant-based burger hype fades, what's next for alt-protein? Redefine Meat targets premium whole cuts like flank steak and lamb kofta for...
GrubMarket has acquired more than 60 food distributors to build a tech-enabled national network, filing confidentially for an IPO where investors will...
Autonomous vehicle pioneer Sebastian Thrun has unveiled Dulo, a stealth robotics startup developing foundation models for hardware design to enable...
Two AI deals reveal diverging paths this week.
A new ensemble machine learning model predicts similarity between odor mixtures with high accuracy (median RMSE of 0.08), advancing efforts to...
Venture capital is concentrating in defense tech, AI infrastructure, and physical AI, backed by surging semiconductor corporate investment.
AI is rapidly becoming central to healthcare, from Epic's expansions in clinical tools to biopharma giants funding drug discovery tech.
What does...
Werewolf Therapeutics' all-stock merger with Ambros Therapeutics values Ambros at $500 million and Werewolf at $47.5 million, while securing a $150...
Rivian’s decision to spin out its battery technology unit with a fresh $150 million round signals a clear strategic pivot, freeing the EV maker to...
Edesa Biotech shares fell nearly 13% in premarket trading after pricing a $25 million public offering of 3.87 million shares and warrants. The move...
Hello and welcome! I'm Boston Tech Funding Radar, your dedicated curator for news and analysis on US high-tech startups. After scanning 120 articles...
You've reached the end